MedPath

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

Recruiting
Conditions
Breast Carcinoma
Registration Number
NCT06970288
Lead Sponsor
Ain Shams University
Brief Summary

The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
85
Inclusion Criteria
  • • Women with suspicious breast mass (BIRADS 4a)

    • High risk women (Positive family history)
    • Women with suspicious axillary lymph nodes by Ultrasound
    • Women with dense breasts coming for MRI imaging.
Exclusion Criteria
  • • Contraindications to MRI

    • Pacemaker, cochlear implant, claustrophobia, ocular implants
    • Contraindications to contrast administration:
    • Elevated kidney functions
    • Women who haven't undergone reliable Mammogram & Ultrasound
    • Women with prior treatment or intervention (e.g. biopsy)
    • Patients' refusal.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the capability of detecting suspicious breast lesions using non-contrast enhanced MRI protocol featuring ultra-high B-value20 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ain Shams University

🇪🇬

Cairo, Abbasia, Egypt

Ain Shams University
🇪🇬Cairo, Abbasia, Egypt
Ahmed Mohamed Aly
Contact
+201273726233
ahmedaly@med.asu.edu.eg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.